Resolution of SLE-related soft-tissue calcification following haematopoietic stem cell transplantation

Nephrology Dialysis Transplantation

Volumn 23, Issue 8, 2008, Pages 2679-2684

  Mandelbrot, Didier A ^a   Santos, Peter W ^b   Burt, Richard K ^c   Oyama, Yu ^c   Block, Geoffrey A ^d   Ahya, Shubhada N ^c   Rosa, Robert M ^c   Traynor, Ann E ^e  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e MaineGeneral Health   (United States)

Author keywords

Calcinosis; Calciphylaxis; Haematopoietic stem cell transplantation; Systemic lupus erythematosis

Indexed keywords

CYCLOPHOSPHAMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; WARFARIN;

ANAMNESIS; ARTICLE; CALCINOSIS; CASE REPORT; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMODIALYSIS; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; SEROLOGY; SOFT TISSUE CALCIFICATION; TISSUE NECROSIS; TREATMENT FAILURE; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ARM; CALCINOSIS; CALCIPHYLAXIS; CONNECTIVE TISSUE DISEASES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEG; LUPUS ERYTHEMATOSUS, SYSTEMIC; SKIN ULCER;

EID: 48749093606     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn036     Document Type: Article

References (46)

1. Whyte MP. Extraskeletal (ectopic) calcification and ossification. In: Favus MJ (ed). Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 4th edn, Philadelphia: Lippincott Williams & Wilkins, 1999, 427-429
2. Angelis M, Wong LL, Myers SA et al. Calciphylaxis in patients on haemodialysis: a prevalence study. Surgery 1997; 122: 1083-1089; discussion 1089-1090
3. Fine A, Zacharias J. Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy. Kidney Int 2002; 61: 2210-2217
4. Au S, Crawford RI. Three-dimensional analysis of a calciphylaxis plaque: clues to pathogenesis. J Am Acad Dermatol 2002; 47: 53-57
5. Fischer AH, Morris DJ. Pathogenesis of calciphylaxis: study of three cases with literature review. Hum Pathol 1995; 26: 1055-1064
6. Selye H. Calciphylaxis. Chicago: University of Chicago Press, 1962
7. Rogers NM, Teubner DJ, Coates PT. Calcific uraemic arteriolopathy: advances in pathogenesis and treatment. Semin Dial 2007; 20: 150-157
8. Boulman N, Slobodin G, Rozenbaum M et al. Calcinosis in rheumatic diseases. Semin Arthritis Rheum 2005; 34: 805-812
9. Traynor AE, Schroeder J, Rosa RM et al. Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stem-cell transplantation: a phase I study. Lancet 2000; 356: 701-707
10. Traynor AE, Barr WG, Rosa RM et al. Haematopoietic stem cell transplantation for severe and refractory lupus. Analysis after five years and fifteen patients. Arthritis Rheum 2002; 46: 2917-2923
11. Burt RK, Traynor A, Statkute L et al. Nonmyeloablative haematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA 2006; 295: 527-535
12. Wilmer WA, Voroshilova O, Singh I et al. Transcutaneous oxygen tension in patients with calciphylaxis. Am J Kidney Dis 2001; 37: 797-806
13. Bleyer AJ, Choi M, Igwemezie B et al. A case control study of proximal calciphylaxis. Am J Kidney Dis 1998; 32: 376-383
14. Kabir DI, Lorincz AL. Chronic disseminated lupus erythematosus and calcinosis cutis. Arch Dermatol 1965; 92: 328-330
15. Nomura M, Okada N, Okada M et al. Large subcutaneous calcification in systemic lupus erythematosus. Arch Dermatol 1990; 126: 1057-1059
16. Ahmed S, O'Neill KD, Hood AF et al. Calciphylaxis is associated with hyperphosphataemia and increased osteopontin expression by vascular smooth muscle cells. Am J Kidney Dis 2001; 37: 1267-1276
17. Giachelli CM. Vascular calcification mechanisms. J Am Soc Nephrol 2004; 15: 2959-2964
18. Chen NX, O'Neill KD, Duan D et al. Phosphorus and uraemic serum up-regulate osteopontin expression in vascular smooth muscle cells. Kidney Int 2002; 62: 1724-1731
19. Luo G, Ducy P, McKee MD et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997; 386: 78-81
20. Wallin R, Cain D, Sane DC. Matrix Gla protein synthesis and gamma-carboxylation in the aortic vessel wall and proliferating vascular smooth muscle cells - a cell system which resembles the system in bone cells. Thromb Haemost 1999; 82: 1764-1767
21. Price PA, June HH, Buckley JR et al. Osteoprotegerin inhibits artery calcification induced by warfarin and by vitamin D. Arterioscler Thromb Vasc Biol 2001; 21: 1610-1616
22. Coates T, Kirkland GS, Dymock RB et al. Cutaneous necrosis from calcific uraemic arteriolopathy. Am J Kidney Dis 1998; 32: 384-391
23. Bundin JA, Feldman J. Soft tissue calcifications in systemic lupus erythematosus. Am J Roentgenol Radium Ther Nucl Med 1975; 124: 358-364
24. Bhatia S, Silverberg NB, Don PC et al. Extensive calcinosis cutis in association with systemic lupus erythematosus. Acta Derm Venereol 2001; 81: 446-447
25. Rothe MJ, Grant-Kels JM, Rothfield NF. Extensive calcinosis cutis with systemic lupus erythematosus. Arch Dermatol 1990; 126: 1060-1063
26. Minami A, Suda K, Kaneda K et al. Extensive subcutaneous calcification of the forearm in systemic lupus erythematosus. J Hand Surg [Br] 1994; 19: 638-641
27. Keats TE. The collagen diseases: a demonstration of the nonspecificity of their extrapulmonary manifestations. Am J Roentgenol Radium Ther Nucl Med 1961; 86: 938-943
28. Davies CA, Jeziorska M, Freemont AJ et al. Expression of osteonectin and matrix Gla protein in scleroderma patients with and without calcinosis. Rheumatology (Oxford) 2006; 45:1349-1355
29. Lian JB, Skinner M, Glimcher MJ et al. The presence of gamma-carboxyglutamic acid in the proteins associated with ectopic calcification. Biochem Biophys Res Commun 1976; 73: 349-355
30. Okada J, Nomura M, Shirataka M et al. Prevalence of soft tissue calcifications in patients with SLE and effects of alfacarcidol. Lupus 1999; 8: 456-461
31. El-Magadmi M, Bodill H, Ahmad Y et al. Systemic lupus erythematosus: an independent risk factor for endothelial dysfunction in women. Circulation 2004; 110: 399-404
32. Asanuma Y, Oeser A, Shintani AK et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003; 349: 2407-2415
33. Stenvinkel P, Ketteler M, Johnson RJ et al. IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uraemia - the good, the bad, and the ugly. Kidney Int 2005; 67: 1216-1233
34. Doherty TM, Asotra K, Fitzpatrick LA et al. Calcification in atherosclerosis: bone biology and chronic inflammation at the arterial crossroads. Proc Natl Acad Sci U S A 2003; 100: 11201-11206
35. Tanaka Y, Watanabe K, Suzuki M et al. Spontaneous production of bone-resorbing lymphokines by B cells in patients with systemic lupus erythematosus. J Clin Immunol 1989; 9: 415-420
36. Heiss A, DuChesne A, Denecke B et al. Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles. J Biol Chem2003; 278: 13333-13341
37. Lebreton JP, Joisel F, Raoult JP et al. Serum concentration of human alpha 2 HS glycoprotein during the inflammatory process: evidence that alpha 2 HS glycoprotein is a negative acute-phase reactant. J Clin Invest 1979; 64: 1118-1129
38. Ketteler M, Bongartz P, Westenfeld R et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study. Lancet 2003; 361: 827-833
39. Cozzolino M, Galassi A, Biondi ML et al. Serum fetuin-A levels link inflammation and cardiovascular calcification in haemodialysis patients. Am J Nephrol 2006; 26: 423-429
40. Block GA. Prevalence and clinical consequences of elevated Ca x P product in haemodialysis patients. Clin Nephrol 2000; 54: 318-324
41. Arch-Ferrer JE, Beenken SW, Rue LW et al. Therapy for calciphylaxis: an outcome analysis. Surgery 2003; 134: 941-944; discussion 944-945
42. Velasco N, MacGregor MS, Innes A et al. Successful treatment of calciphylaxis with cinacalcet - an alternative to parathyroidectomy? Nephrol Dial Transplant 2006; 21: 1999-2004
43. Russell R, Brookshire MA, Zekonis M et al. Distal calcific uraemic arteriolopathy in a haemodialysis patient responds to lowering of Ca x P product and aggressive wound care. Clin Nephrol 2002; 58: 238-243
44. Cicone JS, Petronis JB, Embert CD et al. Successful treatment of calciphylaxis with intravenous sodium thiosulfate. Am J Kidney Dis 2004; 43: 1104-1108
45. Podymow T, Wherrett C, Burns KD. Hyperbaric oxygen in the treatment of calciphylaxis: a case series. Nephrol Dial Transplant 2001; 16: 2176-2180
46. Elhasid R, Rowe JM, Berkowitz D et al. Disappearance of diffuse calcinosis following autologous stem cell transplantation in a child with autoimmune disease. Bone Marrow Transplant 2004; 33: 1257-1259